Chemistry and pharma Why the AI drug revolution has yet to deliver Speed, safety and smarter molecules have yet to translate into better medicines reaching patients. The real breakthrough may come from rethinking what we ask AI to do in the lab, writes Robert Roe Latest Content Accelerating Early-Stage Drug Discovery: How Novalix Integrates CDD Vault and StarDrop for Smarter R&D Simulations Plus announces strategic collaboration to advance AI modelling in pharma Optibrium introduces graphical interface for QuanSA to enhance ligand-based affinity predictions New technologies QC Ware launches Promethium for chemical and materials discovery PhoreMost enhances drug discovery process Optibrium appoints Dr Hamed Tabatabaei Ghomi as Head of Research White papers Accelerating Early-Stage Drug Discovery: How Novalix Integrates CDD Vault and StarDrop for Smarter R&D As the drug discovery community navigates the transition from manual, paper-based workflows to digitally enhanced environments, CROs like Novalix are leading the charge. Discover how centralizing data with CDD Vault and Optibrium's StarDrop™ has supercharged the organisation's efficiency in early-stage research. Protecting bioanalytical data integrity from bench to report Discover how Thermo Scientific™ Watson™ LIMS software safeguards data integrity in bioanalytical studies through traceability, compliance, and automation, reducing regulatory risk and enhancing productivity across the entire bioanalytical process. Future-proofing your lab: key considerations for upgrading or switching chromatography data systems This White Paper guides you in determining whether upgrading your existing system is sufficient or if transitioning to a new CDS is the better, future-ready option. Webcasts On Demand: Free Online Panel Discussion | LIMS innovation boosts precision and security Free Energy Perturbation: How Computational Chemistry Saves Time In Drug Discovery More content Accelerating Early-Stage Drug Discovery: How Novalix Integrates CDD Vault and StarDrop for Smarter R&D Simulations Plus announces strategic collaboration to advance AI modelling in pharma Optibrium introduces graphical interface for QuanSA to enhance ligand-based affinity predictions Earendil Labs secures $787 million to scale AI-driven biologics discovery and development UK consortium to help accelerate adoption of low carbon medicinal manufacturing ELRIG Announces Prof Hazel Screen and Dr Dave Powell as Keynote Speakers for Advances in Cell-based Screening 2026 Why the AI drug revolution has yet to deliver Peter Coveney: the challenges quantum computing systems must overcome for use in the lab Green chemistry in the lab: improving education and sustainable research The molecular fingerprint: How light and logic are advancing chemistry research CCDC announces AI technology partnership with Sapio Sciences SQC enables simulation of quantum physics and chemistry with the launch of its "Quantum Twins" Pagination Page 1 Next page Next ›
